PFE

Q: What is the price of Pfizer (PFE) today?

The current price of Pfizer (PFE) is $ 27.41, representing a 36.17% gain over the past year. The stock began the year trading around $ 24.90 and is currently priced at $ 27.41. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Pfizer (PFE) pay dividends?

In the last year, Pfizer (PFE) distributed dividends in the month of March, totaling $ 0.43. The Dividend Yield for the last 12 months is 6.07%.

Q: Is Pfizer (PFE) a good investment?

Pfizer (PFE) is currently trading at $ 27.41 with a P/E ratio of 20.72%. This represents a 2,793% premium compared to its historical average P/E. Over the past year, the stock has gained 36.17 and paid $ 0.43 in dividends, resulting in a dividend yield of 6.07%. The total shareholder return over the same period was 36.17%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Pfizer Inc.

Price

$ 27.41

return (12m)

36.17%

p/e

20.72

p/bv

1.73

DIVIDEND YIELD

6.07%

PFE price

PFE

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment PFE

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.40%

3 months

9.38%

1 year

36.17%

2 years

18.65%

5 years

-5.53%

10 years

29.87%

Fundamentals PFE

review the fundamentals of Pfizer shares

P/E

20.72

Sector: -3.90 Industry: -3.90

P/S (PSR)

2.57

Sector: -3.94 Industry: -3.94

P/BV

1.73

Sector: 1.83 Industry: 1.83

DIVIDEND YIELD (DY)

6.07%

Sector: - Industry: -

ROA

0.00%

Sector: -61.11% Industry: -61.11%

ROE

8.35%

Sector: -61.17% Industry: -61.17%

ROIC

7.33%

Sector: -1,194.38% Industry: -1,194.38%

NET MARGIN

12.42%

Sector: -39.18% Industry: -39.18%

GROSS MARGIN

74.33%

Sector: 38.38% Industry: 38.38%

OPERATING MARGIN

25.26%

Sector: -39.32% Industry: -39.32%

EV/EBITDA

10.12

Sector: -3.73 Industry: -3.73

EV/EBIT

15.80

Sector: -3.95 Industry: -3.95

PRICE-TO-ASSETS

Sector: 1.35 Industry: 1.35

BVPS

16.37

Sector: 1.90 Industry: 1.90

EPS

1.37

Sector: -2.05 Industry: -2.05

EQUITY-TO-ASSETS RATIO

Sector: 0.42 Industry: 0.42

LIABILITIES / ASSETS

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

-5.10%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-18.78%

Sector: - Industry: -

FAIR VALUE OF Pfizer ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 27.41

Fair Value

$ 0.00

Upside/Downside Return potential.

-18.05%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PFE

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	21.84	7.39	33.81%	2.14%	$ 585.48 B	28.46%
ABBV	87.32	0.00	0.00%	3.18%	$ 369.02 B	6.91%
NVO	10.48	5.40	51.50%	4.56%	$ 164.23 B	33.05%
MRK	16.43	0.00	0.00%	2.71%	$ 300.00 B	28.08%
AZN	30.87	6.48	20.99%	1.57%	$ 315.61 B	17.41%
GILD	20.39	7.67	37.62%	2.28%	$ 173.52 B	28.90%
BMY	17.20	-3.56	-20.72%	4.18%	$ 121.35 B	14.64%
ZTS	19.33	15.51	80.25%	1.72%	$ 51.66 B	28.23%
REGN	17.42	2.51	14.41%	0.47%	$ 78.47 B	31.41%
HALO	24.01	155.91	649.21%	0.00%	$ 7.61 B	22.69%
AMGN	24.32	21.66	89.06%	2.78%	$ 187.54 B	20.98%
MCK	24.84	-1,089.08	-4,383.84%	0.36%	$ 107.82 B	1.09%
VRTX	28.19	5.97	21.18%	0.00%	$ 111.43 B	32.94%
CAH	30.39	-18.71	-61.56%	0.95%	$ 50.52 B	0.68%
ADMA	14.89	4.58	30.78%	0.00%	$ 2.19 B	28.80%
BIIB	20.16	1.43	7.08%	0.00%	$ 26.07 B	13.07%
HRMY	9.96	1.82	18.24%	0.00%	$ 1.58 B	18.27%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

PFE Historical Dividends

current DY: 6.07%

5-year average DY: 5.18%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	01/23/2026	03/06/2026	0,43000000
Dividends	11/07/2025	12/01/2025	0,43000000
Dividends	07/25/2025	09/02/2025	0,43000000
Dividends	05/09/2025	06/13/2025	0,43000000
Dividends	01/24/2025	03/07/2025	0,43000000
Dividends	11/08/2024	12/02/2024	0,42000000
Dividends	07/26/2024	09/03/2024	0,42000000
Dividends	05/10/2024	06/14/2024	0,42000000
Dividends	01/26/2024	03/01/2024	0,42000000
Dividends	11/10/2023	12/04/2023	0,41000000
Dividends	07/28/2023	09/05/2023	0,41000000
Dividends	05/12/2023	06/09/2023	0,41000000
Dividends	01/25/2023	03/03/2023	0,41000000
Dividends	11/04/2022	12/05/2022	0,40000000
Dividends	07/29/2022	09/06/2022	0,40000000
Dividends	05/13/2022	06/10/2022	0,40000000
Dividends	01/28/2022	03/04/2022	0,40000000
Dividends	11/05/2021	12/06/2021	0,39000000
Dividends	07/30/2021	09/07/2021	0,39000000
Dividends	05/07/2021	06/04/2021	0,03900000
Dividends	01/29/2021	03/05/2021	0,39000000
Dividends	11/06/2020	12/01/2020	0,38000000
Dividends	07/31/2020	09/01/2020	0,38000000
Dividends	05/08/2020	06/05/2020	0,38000000
Dividends	01/31/2020	03/06/2020	0,38000000
Dividends	11/08/2019	12/02/2019	0,36000000
Dividends	08/02/2019	09/03/2019	0,36000000
Dividends	05/10/2019	06/07/2019	0,36000000
Dividends	02/01/2019	03/01/2019	0,36000000
Dividends	11/09/2018	12/03/2018	0,34000000
Dividends	08/03/2018	09/04/2018	0,34000000
Dividends	05/11/2018	06/01/2018	0,34000000
Dividends	02/02/2018	03/01/2018	0,34000000
Dividends	11/10/2017	12/01/2017	0,32000000
Dividends	08/04/2017	09/01/2017	0,32000000
Dividends	05/12/2017	06/01/2017	0,32000000
Dividends	02/03/2017	03/01/2017	0,32000000
Dividends	11/11/2016	12/01/2016	0,30000000
Dividends	08/05/2016	09/01/2016	0,30000000
Dividends	05/13/2016	06/01/2016	0,30000000
Dividends	02/05/2016	03/02/2016	0,30000000
Dividends	11/06/2015	12/01/2015	0,28000000
Dividends	08/07/2015	09/02/2015	0,28000000
Dividends	05/08/2015	06/02/2015	0,28000000
Dividends	02/06/2015	03/03/2015	0,28000000
Dividends	11/07/2014	12/02/2014	0,26000000
Dividends	08/01/2014	09/03/2014	0,26000000
Dividends	05/09/2014	06/03/2014	0,26000000
Dividends	02/07/2014	03/04/2014	0,26000000
Dividends	11/08/2013	12/03/2013	0,24000000
Dividends	08/02/2013	09/04/2013	0,24000000
Dividends	05/10/2013	06/04/2013	0,24000000
Dividends	02/01/2013	03/05/2013	0,24000000
Dividends	11/09/2012	12/04/2012	0,22000000
Dividends	08/03/2012	09/05/2012	0,22000000
Dividends	05/11/2012	06/05/2012	0,22000000
Dividends	02/03/2012	03/06/2012	0,22000000
Dividends	11/11/2011	12/06/2011	0,20000000
Dividends	08/05/2011	09/06/2011	0,20000000
Dividends	05/13/2011	06/07/2011	0,20000000
Dividends	02/04/2011	03/01/2011	0,20000000
Dividends	11/08/2010	12/01/2010	0,18000000
Dividends	08/06/2010	09/01/2010	0,18000000
Dividends	05/07/2010	06/01/2010	0,18000000
Dividends	02/05/2010	03/02/2010	0,18000000
Dividends	11/06/2009	12/01/2009	0,16000000
Dividends	08/07/2009	09/02/2009	0,16000000
Dividends	05/08/2009	06/02/2009	0,16000000
Dividends	02/06/2009	03/03/2009	0,32000000
Dividends	11/07/2008	12/02/2008	0,32000000
Dividends	08/08/2008	09/03/2008	0,32000000
Dividends	05/09/2008	06/03/2008	0,32000000
Dividends	02/08/2008	03/04/2008	0,32000000
Dividends	11/09/2007	12/04/2007	0,29000000
Dividends	08/10/2007	09/05/2007	0,29000000
Dividends	05/11/2007	06/05/2007	0,29000000
Dividends	02/09/2007	03/06/2007	0,29000000
Dividends	11/10/2006	12/05/2006	0,24000000
Dividends	08/11/2006	09/05/2006	0,24000000
Dividends	05/12/2006	06/06/2006	0,24000000
Dividends	02/10/2006	03/07/2006	0,24000000
Dividends	11/11/2005	12/06/2005	0,19000000
Dividends	08/12/2005	09/06/2005	0,19000000
Dividends	05/13/2005	06/07/2005	0,19000000
Dividends	02/11/2005	03/08/2005	0,19000000
Dividends	11/12/2004	12/03/2004	0,17000000
Dividends	08/13/2004	09/03/2004	0,17000000
Dividends	05/14/2004	06/04/2004	0,17000000
Dividends	02/13/2004	03/05/2004	0,17000000
Dividends	11/14/2003	12/04/2003	0,15000000
Dividends	08/15/2003	09/04/2003	0,15000000
Dividends	05/16/2003	06/05/2003	0,15000000
Dividends	01/17/2003	02/14/2003	0,15000000
Dividends	11/15/2002	12/05/2002	0,13000000
Dividends	08/16/2002	09/05/2002	0,13000000
Dividends	05/17/2002	06/06/2002	0,13000000
Dividends	02/15/2002	03/07/2002	0,13000000
Dividends	11/16/2001	12/06/2001	0,11000000
Dividends	08/17/2001	09/06/2001	0,11000000
Dividends	05/18/2001	06/07/2001	0,11000000
Dividends	02/16/2001	03/08/2001	0,11000000
Dividends	11/17/2000	12/07/2000	0,09000000
Dividends	08/18/2000	09/07/2000	0,09000000
Dividends	05/11/2000	06/08/2000	0,09000000
Dividends	02/18/2000	03/09/2000	0,09000000
Dividends	11/12/1999	12/09/1999	0,08000000
Dividends	08/06/1999	09/09/1999	0,08000000
Dividends	05/07/1999	06/10/1999	0,07333333
Dividends	02/12/1999	03/11/1999	0,07333333
Dividends	11/06/1998	12/10/1998	0,06333333
Dividends	08/07/1998	09/10/1998	0,06333333
Dividends	05/08/1998	06/11/1998	0,06333333
Dividends	02/06/1998	03/12/1998	0,06333333
Dividends	11/07/1997	12/11/1997	0,05666667
Dividends	08/01/1997	09/11/1997	0,05666667
Dividends	05/09/1997	06/12/1997	0,05665000
Dividends	02/07/1997	03/13/1997	0,05665000
Dividends	11/08/1996	12/12/1996	0,05001667
Dividends	08/02/1996	09/12/1996	0,05001667
Dividends	05/10/1996	06/13/1996	0,05001667
Dividends	02/09/1996	03/14/1996	0,05001667
Dividends	11/10/1995	12/21/1995	0,04331667
Dividends	08/04/1995	09/21/1995	0,04331667
Dividends	05/12/1995	06/15/1995	0,04331667
Dividends	02/10/1995	03/16/1995	0,04331667
Dividends	11/11/1994	12/15/1994	0,03915833
Dividends	08/05/1994	09/15/1994	0,03915833
Dividends	05/13/1994	06/16/1994	0,03915833
Dividends	02/11/1994	03/17/1994	0,03915833
Dividends	11/12/1993	12/16/1993	0,03499167
Dividends	08/06/1993	09/16/1993	0,03499167
Dividends	05/14/1993	06/17/1993	0,03499167
Dividends	02/12/1993	03/18/1993	0,03499167
Dividends	11/20/1992	12/17/1992	0,03083333
Dividends	08/07/1992	09/17/1992	0,03083333
Dividends	05/15/1992	06/18/1992	0,03083333
Dividends	02/07/1992	03/19/1992	0,03083333
Dividends	11/15/1991	12/19/1991	0,02750833
Dividends	08/07/1991	09/19/1991	0,02750833
Dividends	05/17/1991	06/20/1991	0,02750833
Dividends	02/28/1991	03/21/1991	0,02750833
Dividends	11/16/1990	12/20/1990	0,02497917
Dividends	08/10/1990	09/20/1990	0,02497917
Dividends	05/18/1990	06/21/1990	0,02497917
Dividends	02/09/1990	03/22/1990	0,02497917

ABOUT Pfizer

Pfizer Inc.

Average Investor10 user rating

4.0 (820 people)

United States

84 years

Founded: 1942

1951

Time since IPO - 75 years

78.500

Employees

Pfizer Inc. operates in the Healthcare sector, within the Biotechnology & Pharmaceuticals industry. Founded in 1849, the company researches, develops, manufactures, and commercializes prescription medicines and vaccines worldwide.

Pfizer generates revenue primarily from proprietary biopharmaceutical products across multiple therapeutic areas.

Its core business areas include:

Internal Medicine, focused on cardiovascular and metabolic diseases.
Oncology, including targeted therapies and biologics.
Vaccines, covering infectious diseases across age groups.
Inflammation and Immunology.
Rare Diseases.
Hospital products, including sterile injectables and anti-infectives.

The company distributes products in more than 125 countries, serving hospitals, clinics, pharmacies, wholesalers, and government agencies.

Performance is influenced by patent cycles, regulatory approvals, research and development productivity, pricing dynamics, global health policies, and competitive pressures within the pharmaceutical industry.

Pfizer shares trade on the New York Stock Exchange (NYSE) under the ticker PFE.

History and Development

Pfizer was founded in 1849 in Brooklyn, New York, initially producing chemical compounds and later expanding into pharmaceuticals.

During the twentieth century, the company grew through research-driven innovation and international expansion.

In the 2000s, Pfizer strengthened its portfolio through major acquisitions, including Warner-Lambert, Pharmacia, and Wyeth, expanding its presence in cardiovascular medicine, oncology, biotechnology, and vaccines.

More recently, Pfizer gained global visibility through the development of a COVID-19 vaccine in partnership with BioNTech.

In recent years, the company has focused on pipeline development, portfolio optimization, and expansion into high-growth therapeutic areas, maintaining its position as one of the largest global pharmaceutical companies.

Additional Information

Pfizer Inc. (United States) is listed on the NYSE and has a market capitalization of $161.03 Billions, with shareholders equity totaling $93.10 Billions.

The company employs approximately 78.500 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Pfizer Inc. reported $62.58 Billions in revenue, generating net income of $7.77 Billions.

Key financial metrics include a P/E ratio of 20.72, a price-to-book (P/B) ratio of 1.73, and a trailing twelve-month dividend yield of 6.07%.

The company trades under the ticker PFE.

Market cap

$ 161.03 Billions

Net worth

$ 93.10 Billions

$ 93,096,000,000.00

Assets

$ -

Total Shares Outstanding

5.69 Billions

5,686,000,000

Average Daily Trading Volume

$ 44.93 Millions

$ 44,932,048.82

Sector

Health Care

Industry

Biotechnology

PFE

revenue by Business Segment Pfizer

Revenue by Region Pfizer

PFE revenue and profits

Financial Results PFE

DRAG THE FRAME TO SEE MORE DATA

PFE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 876.58 27,66% (12M)

P/E

24.84

0.36%

ROE

-4,383.84%

P/BV

-1,089.08

CAH - Cardinal Health

$ 216.80 66,99% (12M)

P/E

30.39

0.95%

ROE

-61.56%

P/BV

-18.71

JNJ - Johnson & Johnson

$ 243.50 64,95% (12M)

P/E

21.84

2.14%

ROE

33.81%

P/BV

7.39

ABBV - AbbVie

$ 212.90 26,65% (12M)

P/E

87.32

3.18%

ROE

0.00%

P/BV

0.00

MRK - Merck & Co.

$ 122.97 60,95% (12M)

P/E

16.43

2.71%

ROE

0.00%

P/BV

0.00

AZN - AstraZeneca

$ 206.17 54,28% (12M)

P/E

30.87

1.57%

ROE

20.99%

P/BV

6.48

BMY - Bristol-Myers Squibb

$ 59.42 24,36% (12M)

P/E

17.20

4.18%

ROE

-20.72%

P/BV

-3.56

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 876.58 27,66% (12 M)

P/L

24.84

0.36%

ROE

-4,383.84%

P/VP

-1,089.08

CAH - Cardinal Health

$ 216.80 66,99% (12 M)

P/L

30.39

0.95%

ROE

-61.56%

P/VP

-18.71

JNJ - Johnson & Johnson

$ 243.50 64,95% (12 M)

P/L

21.84

2.14%

ROE

33.81%

P/VP

7.39

ABBV - AbbVie

$ 212.90 26,65% (12 M)

P/L

87.32

3.18%

ROE

0.00%

P/VP

0.00

MRK - Merck & Co.

$ 122.97 60,95% (12 M)

P/L

16.43

2.71%

ROE

0.00%

P/VP

0.00

AZN - AstraZeneca

$ 206.17 54,28% (12 M)

P/L

30.87

1.57%

ROE

20.99%

P/VP

6.48

BMY - Bristol-Myers Squibb

$ 59.42 24,36% (12 M)

P/L

17.20

4.18%

ROE

-20.72%

P/VP

-3.56

Frequently Asked Questions

What is the price of Pfizer (PFE) today?

The current price of Pfizer (PFE) is $ 27.41, representing a 36.17% gain over the past year. The stock began the year trading around $ 24.90 and is currently priced at $ 27.41. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Pfizer (PFE) pay dividends?

In the last year, Pfizer (PFE) distributed dividends in the month of March, totaling $ 0.43. The Dividend Yield for the last 12 months is 6.07%.

Is Pfizer (PFE) a good investment?

Pfizer (PFE) is currently trading at $ 27.41 with a P/E ratio of 20.72%. This represents a 2,793% premium compared to its historical average P/E. Over the past year, the stock has gained 36.17 and paid $ 0.43 in dividends, resulting in a dividend yield of 6.07%. The total shareholder return over the same period was 36.17%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Pfizer (PFE) stock?

You can buy Pfizer (PFE) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PFE and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Pfizer (PFE) yield today?

Over the past month, Pfizer (PFE) has returned 0.40% — 36.17% over the past year, and -5.53% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 1.72 per share in dividends, resulting in a dividend yield of 6.07%.

If you were to purchase 100 shares of Pfizer (PFE) today at the current price of $ 27.41 your total investment would be $ 2,741.01.

Based on historical performance, the investment would have grown to approximately:

$ 3,732.43 after 1 year
$ 2,589.43 after 5 years
$ 3,559.75 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PFE

Pfizer Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PFE

review the fundamentals of Pfizer shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

If you had invested (change) 2 years years ago, ago, you would now have

current DY: 6.07%

5-year average DY: 5.18%

type

Ex - Dividend Date

payment date

value

ABOUT Pfizer

Pfizer Inc.

United States

84 years

1951

78.500

History and Development

Additional Information

PROFIT X PRICE PFE

Financial Results PFE

PFE cash flow

Asset, Revenue and Profit Growth - PFE

PFE balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

BMY - Bristol-Myers Squibb

Frequently Asked Questions